Insider Transactions in Q4 2022 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2022
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,361
+9.97%
|
$35,361
$1.47 P/Share
|
|
Dec 01
2022
|
Arvin Yang SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,527
-17.56%
|
$33,162
$6.59 P/Share
|
|
Nov 30
2022
|
Arvin Yang SVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+37.02%
|
-
|